YuLife announces US launch

Broadens reach into global markets

Hemma Visavadia
clock • 1 min read

Life insurtech YuLife has officially launched in the United States (US) after completing several funding rounds, which brought its total investment to $206m (£181m).

Investors in the insurtech include asset management giant T. Rowe Price Associates, Dai-ichi Life, Creandum, LocalGlobe, Target Global, Latitude, Anthemis, OurCrowd, Notion, MMC and Eurazeo. The expansion into the US will allow YuLife to broaden its reach into global markets and upscale its product range. Its current proposition is built upon rewards and benefits to employees for wellness activities and healthy habit changes using a gamified app that incorporates artificial intelligence and behavioural analytics. Sammy Rubin, chief executive and founder of YuLife, commented: "Insur...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual Protection

Two thirds of adults face barriers to securing life cover

Two thirds of adults face barriers to securing life cover

UnderwriteMe research findings

Jaskeet Briah
clock 09 April 2026 • 2 min read
Unpaid carers spend four working days per week supporting elderly relatives

Unpaid carers spend four working days per week supporting elderly relatives

10 hours per week spent on bureaucratic tasks

Jaskeet Briah
clock 08 April 2026 • 2 min read
Probate cases taking nearly two years rise by 131%

Probate cases taking nearly two years rise by 131%

Increased risk of interest accruing on IHT

Jaskeet Briah
clock 07 April 2026 • 2 min read